Laura McLinn
2.4K posts

Laura McLinn
@LauraMclinn
Founding President, Best Day Ever Foundation. Passion for helping patients access treatments. Duchenne mama bear.

.@POTUS: "FDA has just approved a new drug from Regeneron called Otarmeni, a gene therapy curing a rare disease causing deafness." "Here with us is 2-year-old Travis Smith. He was born deaf... He took this miracle cure and now he can hear his mom, Sierra, say, 'I love you.'" ❤️






@DrMakaryFDA @FDACDERDirector: Please help us and signal to @PTCBio that FDA will weigh #RealWorldEvidence and apply consistent standards across CDER/CBER when reviewing #Ataluren for stop-codon #Duchenne. Real-world outcomes truly matter: a 13-year-old running; a 34-year-old maintaining breathing function. Our sons with a nonsense mutation are not eligible for exon-skipping; my son has been in Ataluren trials/extension since 2006 with no side effects. He lost ambulation at 22 (2015) and, at 32, has avoided typical pulmonary decline with 97% pulmonary scores. #RareDisease families can risk losing time/abilities that can’t be regained. #TimeIsMuscle @SecKennedy @POTUS @RonJohnsonWI @SenRonJohnson





@DrMakaryFDA please consider taking a closer look at ataluren for these families. Their stories are so powerful. @SecKennedy @POTUS @RonJohnsonWI

@LauraMclinn @DrMakaryFDA @FDACDERDirector @PTCBio @SecKennedy @POTUS Sadly we have not. Our time is running out, manufacturing has halted for patients in the US. We wish we could share our almost 10 years of real world experience with @DrMakaryFDA




$qure $clpt “The FDA and uniQure, along with Huntington’s disease organizations, are in active dialogue regarding how to interpret AMT-130’s data, Margolin added.” It’s a very interesting article, fda in public is now saying that HD technically can work for the plausible mechanism, it’s a big story.




